Item;Category;"Percentage (%)";"95% CI (%)"
Gender;Male;62.6;55.7–69.5
Female;37.4;30.5–44.3
Education;"Primary school";17.6;12.1–23.1
"High school";46.5;39.4–53.6
College;2.7;0.4–5.0
"University education";33.2;26.5–39.9
"Smoking status";Yes;50.8;43.6–58.0
No;49.2;42.0–56.4
"Disease Duration";"Less than 1 year";18.2;12.7–23.7
"Between 1–5 years";69.5;62.9–76.1
"Between 5–20 years or more";12.3;7.6–17.0
Treatment;ICS+LABA;78;72.1–83.9
LAMA;6.4;2.9–9.9
ICS+LAMA+LABA;9.1;5.0–13.2
ICS;6.4;2.9–9.9
"Inhaler training";"By physician";58.8;51.7–65.9
"By pharmacist";27.3;20.9–33.7
None;13.9;8.9–18.9
"Training using demo inhaler";"By physician";49.7;42.5–56.9
"By pharmacist";5.9;2.5–9.3
None;44.4;37.3–51.5
"Adherence to prescribed therapy";Yes;69;62.4–75.6
No;16.6;11.3–21.9
Sometimes;14.4;9.4–19.4